27
Views
50
CrossRef citations to date
0
Altmetric
Original Article

Occurrence of Clostridium difficile Toxin in Inflammatory Bowel Disease

, &
Pages 61-64 | Received 09 Mar 1982, Accepted 20 May 1982, Published online: 19 Feb 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (9)

George Saffouri, Arjun Gupta, Edward V. Loftus$suffix/text()$suffix/text(), Larry M. Baddour, Darrell S. Pardi & Sahil Khanna. (2017) The incidence and outcomes from Clostridium difficile infection in hospitalized adults with inflammatory bowel disease. Scandinavian Journal of Gastroenterology 52:11, pages 1240-1247.
Read now
Ashwin N Ananthakrishnan & David G Binion. (2010) Impact of Clostridium difficile on inflammatory bowel disease. Expert Review of Gastroenterology & Hepatology 4:5, pages 589-600.
Read now
Saif Musa, Sam Thomson, Matthew Cowan & Tony Rahman. (2010) Clostridium difficile infection and inflammatory bowel disease. Scandinavian Journal of Gastroenterology 45:3, pages 261-272.
Read now
G. Schumacher, B. Kollberg, B. Sandstedt, C. Jorup, L. Grillner, Å. Ljungh & R. Möllby. (1993) A Prospective Study of First Attacks of Inflammatory Bowel Disease and Non-Relapsing Colitis: Microbiologic Findings. Scandinavian Journal of Gastroenterology 28:12, pages 1077-1085.
Read now
. (1993) General Summary. Scandinavian Journal of Gastroenterology 28:sup198, pages 21-24.
Read now
C. Tysk & G. Järnerot. (1993) Seasonal Variation in Exacerbations of Ulcerative Colitis. Scandinavian Journal of Gastroenterology 28:1, pages 95-96.
Read now
H. R. Koelz & P. Bauerfeind. (1988) Mucosal Protecting Agents: First Choice in Uncomplicated Ulcer Disease?. Scandinavian Journal of Gastroenterology 23:sup153, pages 71-80.
Read now
Markku äärimaa. (1987) Medical and Surgical Prophylaxis for Duodenal Ulcer, the Role of Sucralfate. Scandinavian Journal of Gastroenterology 22:sup127, pages 81-85.
Read now
H. Sandberg Gertzen, J. Kjellander, B. Sundberg-Gillar & G. Jarrnerot. (1985) In Vitro Effects of Sulphasalazine, Azodisal Sodium, and Their Metabolites on Clostridium difficile and Some Other Faecal Bacteria. Scandinavian Journal of Gastroenterology 20:5, pages 607-612.
Read now

Articles from other publishers (41)

Dejan Micic, Andres Yarur, Alex Gonsalves, Vijaya L. Rao, Susan Broadaway, Russell Cohen, Sushila Dalal, John N. Gaetano, Laura R. Glick, Ayal Hirsch, Joel Pekow, Atsushi Sakuraba, Seth T. Walk & David T. Rubin. (2018) Risk Factors for Clostridium difficile Isolation in Inflammatory Bowel Disease: A Prospective Study. Digestive Diseases and Sciences 63:4, pages 1016-1024.
Crossref
Fernando Magro, Paolo Gionchetti, Rami Eliakim, Sandro Ardizzone, Alessandro Armuzzi, Manuel Barreiro-de Acosta, Johan Burisch, Krisztina B. Gecse, Ailsa L. Hart, Pieter Hindryckx, Cord Langner, Jimmy K. Limdi, Gianluca Pellino, Edyta Zagórowicz, Tim Raine, Marcus Harbord & Florian Rieder. (2017) Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. Journal of Crohn's and Colitis 11:6, pages 649-670.
Crossref
Julie D’Aoust, Robert Battat & Talat Bessissow. (2017) Management of inflammatory bowel disease with Clostridium difficile infection . World Journal of Gastroenterology 23:27, pages 4986.
Crossref
Noel S. Lee, Suresh Pola, Erik J. Groessl, Jesus Rivera-Nieves & Samuel B. Ho. (2016) Opportunities for Improvement in the Care of Patients Hospitalized for Inflammatory Bowel Disease-Related Colitis. Digestive Diseases and Sciences 61:4, pages 1003-1012.
Crossref
A. Dignass, R. Eliakim, F. Magro, C. Maaser, Y. Chowers, K. Geboes, G. Mantzaris, W. Reinisch, J.-F. Colombel, S. Vermeire, S. Travis, J.O. Lindsay & G. van Assche. (2014) Segundo Consenso Europeo basado en evidencia sobre el diagnóstico y tratamiento de la colitis ulcerosa crónica idiopática Parte 1: Definiciones y diagnóstico (versión española). Revista de Gastroenterología de México 79:4, pages 263-289.
Crossref
Gwen M. C. Masclee, John Penders, Daisy M. A. E. Jonkers, Petra F. G. Wolffs & Marie J. Pierik. (2013) Is Clostridium difficile Associated With Relapse of Inflammatory Bowel Disease? Results From a Retrospective and Prospective Cohort Study in the Netherlands. Inflammatory Bowel Diseases 19:10, pages 2125-2131.
Crossref
Sheela S. Reddy & Lawrence J. Brandt. (2013) Clostridium difficile Infection and Inflammatory Bowel Disease. Journal of Clinical Gastroenterology 47:8, pages 666-671.
Crossref
Axel Dignass, Rami Eliakim, Fernando Magro, Christian Maaser, Yehuda Chowers, Karel Geboes, Gerassimos Mantzaris, Walter Reinisch, Jean-Frederic Colombel, Severine Vermeire, Simon Travis, James O. Lindsay & Gert Van Assche. (2012) Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis. Journal of Crohn's and Colitis 6:10, pages 965-990.
Crossref
Victor O. Badger, Nate A. Ledeboer, Mary Beth Graham & Charles E. EdmistonJr.Jr.. (2012) Clostridium difficile . Journal of Parenteral and Enteral Nutrition 36:6, pages 645-662.
Crossref
D. S. Rampton & F. Shanahan. (2011) Increased health burden associated with Clostridium difficile diarrhoea in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 34:3, pages 394-395.
Crossref
Abhishek Deshpande, Vinay Pasupuleti, Preethi Patel, Gati Ajani, Geraldine Hall, Bo Hu, Anil Jain & David D.K. Rolston. (2011) Repeat Stool Testing to Diagnose Clostridium difficile Infection Using Enzyme Immunoassay Does Not Increase Diagnostic Yield. Clinical Gastroenterology and Hepatology 9:8, pages 665-669.e1.
Crossref
Ashwin N. Ananthakrishnan, Emily L. McGinley, Kia Saeian & David G. Binion. (2011) Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease. Inflammatory Bowel Diseases 17:4, pages 976-983.
Crossref
J. R. Goodhand, W. Alazawi & D. S. Rampton. (2011) Systematic review: Clostridium difficile and inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 33:4, pages 428-441.
Crossref
Preetika Sinh, Terrence A. Barrett & Laura Yun. (2011) Clostridium difficile Infection and Inflammatory Bowel Disease: A Review . Gastroenterology Research and Practice 2011, pages 1-11.
Crossref
Ashwin N. Ananthakrishnan, Mazen Issa & David G. Binion. (2010) Clostridium Difficile and Inflammatory Bowel Disease. Medical Clinics of North America 94:1, pages 135-153.
Crossref
Ashwin N. Ananthakrishnan, Mazen Issa & David G. Binion. (2009) Clostridium Difficile and Inflammatory Bowel Disease. Gastroenterology Clinics of North America 38:4, pages 711-728.
Crossref
Evelyn M Clayton, Mary C Rea, Fergus Shanahan, Eamonn M M Quigley, Barry Kiely, Colin Hill & R Paul Ross. (2009) The Vexed Relationship Between Clostridium Difficile and Inflammatory Bowel Disease: An Assessment of Carriage in an Outpatient Setting Among Patients in Remission. The American Journal of Gastroenterology 104:5, pages 1162-1169.
Crossref
Sunny Singh, Lesley A Graff & Charles N Bernstein. (2009) Do NSAIDs, Antibiotics, Infections, or Stress Trigger Flares in IBD?. The American Journal of Gastroenterology 104:5, pages 1298-1313.
Crossref
Mazen Issa, Ashwin N. Ananthakrishnan & David G. Binion. (2008) Clostridium difficile and inflammatory bowel disease. Inflammatory Bowel Diseases 14:10, pages 1432-1442.
Crossref
E.F. Stange, S.P.L. Travis, S. Vermeire, W. Reinisch, K. Geboes, A. Barakauskiene, R. Feakins, J.F. Fléjou, H. Herfarth, D.W. Hommes, L. Kupcinskas, P.L. Lakatos, G.J. Mantzaris, S. Schreiber, V. Villanacci & B.F. Warren. (2008) European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis. Journal of Crohn's and Colitis 2:1, pages 1-23.
Crossref
Hugh James Freeman. (2008) Recent developments on the role of Clostridium difficile in inflammatory bowel disease. World Journal of Gastroenterology 14:18, pages 2794.
Crossref
Javier P. Gisbert & Fernando Gomollón. (2007) Errores frecuentes en el manejo del paciente grave con enfermedad inflamatoria intestinal. Gastroenterología y Hepatología 30:5, pages 294-314.
Crossref
Mazen Issa, Aravind Vijayapal, Mary Beth Graham, Dawn B. Beaulieu, Mary F. Otterson, Sarah Lundeen, Susan Skaros, Lydia R. Weber, Richard A. Komorowski, Josh F. Knox, Jeanne Emmons, Jasmohan S. Bajaj & David G. Binion. (2007) Impact of Clostridium difficile on Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology 5:3, pages 345-351.
Crossref
Molly Perencevich & Robert Burakoff. (2006) Use of antibiotics in the treatment of inflammatory bowel disease. Inflammatory Bowel Diseases 12:7, pages 651-664.
Crossref
K. Koss, M. A. Clark, D. S. A. Sanders, D. Morton, M. R. B. Keighley & J. Goh. (2006) The outcome of surgery in fulminant Clostridium difficile colitis. Colorectal Disease 8:2, pages 149-154.
Crossref
Angela M Meyer, Nizar N Ramzan, Edward V LoftusJrJr, Russell I Heigh & Jonathan A Leighton. (2004) The Diagnostic Yield of Stool Pathogen Studies During Relapses of Inflammatory Bowel Disease. Journal of Clinical Gastroenterology 38:9, pages 772-775.
Crossref
Maria Mylonaki, Louise Langmead, Athanasios Pantes, Frith Johnson & David S Rampton. (2004) Enteric infection in relapse of inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 16:8, pages 775-778.
Crossref
Craig A Solem & Edward V LoftusJr.Jr.. (2004) Management of refractory inflammatory bowel disease. Gastroenterology Clinics of North America 33:2, pages 319-334.
Crossref
Joel V. Weinstock. 2004. Infection and Autoimmunity. Infection and Autoimmunity 649 673 .
Ronni Wolf, Hagit Matz, Edith Orion, Binnur Tüzün & Yalcin Tüzün. (2002) Miscellaneous treatments, I: sulfasalazine and pentoxifylline: unapproved uses, dosages, or indications. Clinics in Dermatology 20:5, pages 531-546.
Crossref
Richard J Farrell & J.Thomas LaMont. (2002) Microbial factors in inflammatory bowel disease. Gastroenterology Clinics of North America 31:1, pages 41-62.
Crossref
Walter R. ThayerJr.Jr. & Vikas Chitnavis. (1994) The case for an infectious etiology. Medical Clinics of North America 78:6, pages 1233-1247.
Crossref
SHIU KUM LAM & CHI KONG CHING. (1994) Sucralfate in clinical practice. Journal of Gastroenterology and Hepatology 9:4, pages 401-411.
Crossref
H. J. Freeman. (1993) Sulphasalazine-induced forms of colitis. InflammoPharmacology 2:3, pages 301-305.
Crossref
Donald J. Hermens & Philip B. MinerJr.Jr.. (1991) Exacerbation of ulcerative colitis. Gastroenterology 101:1, pages 254-262.
Crossref
J. H. Lewis. 1991. Pharmacology of Peptic Ulcer Disease. Pharmacology of Peptic Ulcer Disease 263 300 .
Teri A. Longacre & Cecilia M. Fenoglio-Preiser. 1990. Progress in Surgical Pathology. Progress in Surgical Pathology 27 58 .
R. B. SEWELL, D. KIM & N. D. YEOMANS. (1988) Sucralfate protection against ethanol-induced injury of rat gastric mucosa in vitro and in vivo. Journal of Gastroenterology and Hepatology 3:3, pages 227-233.
Crossref
MAURY E. MULLIGAN. 1988. Clostridium Difficile. Clostridium Difficile 229 256 .
D. A. Burke & A. T. Axon. (1987) Clostridium difficile, sulphasalazine, and ulcerative colitis.. Postgraduate Medical Journal 63:745, pages 955-957.
Crossref
S. L. Gorbach. 1986. Inflammatory Bowel Diseases 1986. Inflammatory Bowel Diseases 1986 9 24 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.